SYNGENE - Swing Trade Analysis with AI Signals

Last Updated Time : 05 Nov 25, 7:43 am

Swing Trade Rating: 3.5

📉 Current Price: ₹650

📊 Optimal Entry Price: ₹640–645 (near 50 DMA and RSI support zone)

📈 Suggested Exit (if holding): ₹675–690 (approaching 200 DMA resistance)

🔷 Positive

• 📈 MACD Positive: 2.97 indicates early bullish momentum
• 📊 Volume Strength: Current volume (4.08L) above 1-week average (3.54L)
• 📉 Low Debt: Debt-to-equity ratio of 0.07 reflects financial prudence
• 📈 DII Buying: Domestic institutional holding increased by 0.57%
• 📈 Quarterly PAT Growth: PAT improved 48.1% QoQ despite prior decline

⚠️ Limitation

• 📉 High P/E: 55.9 vs industry average of 39.3 suggests overvaluation
• 📉 Elevated PEG Ratio: 43.4 implies expensive valuation relative to growth
• 📉 RSI at 49.4: Neutral zone, lacks strong directional signal
• 📉 Below 200 DMA: Price trading under 200 DMA (₹682), indicating resistance
• 📉 Weak ROE & ROCE: ROE at 9.78% and ROCE at 12.8% are modest for the sector

🚫 Company Negative News

• 📉 FII Selling: Foreign institutional holding declined by 0.20%
• 📉 Previous PAT Drop: Prior quarter PAT was ₹174 Cr, now ₹74 Cr

✅ Company Positive News

• 🧪 Biotech Expansion: Continued investment in biologics and contract research services
• 📈 EPS Strength: ₹11.6 supports long-term valuation

🏭 Industry

• 🧬 Biopharma Sector: Supported by global R&D demand and outsourcing trends
• 📉 Valuation Pressure: Sector trading at elevated multiples amid regulatory and cost challenges

🧾 Conclusion

SYNGENE presents a moderate swing trade setup with improving technicals and sector support. While valuation is rich and prior earnings were volatile, institutional interest and MACD strength suggest short-term upside. Entry near ₹640–645 is ideal, with exit near ₹675–690. Watch for RSI breakout and volume confirmation before initiating trades.

I can chart SYNGENE’s price action with support and resistance zones to help you time your trade more precisely.